Literature DB >> 31256720

Are We Getting Closer to the HEART of Hypertensive Heart Disease?

Omar K Khalique1, Natalie A Bello1.   

Abstract

Entities:  

Year:  2019        PMID: 31256720      PMCID: PMC6938583          DOI: 10.1161/HYPERTENSIONAHA.119.13169

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  13 in total

Review 1.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Authors:  Arnfried U Klingbeil; Markus Schneider; Peter Martus; Franz H Messerli; Roland E Schmieder
Journal:  Am J Med       Date:  2003-07       Impact factor: 4.965

2.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

3.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

4.  Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.

Authors:  Javier Díez; Ramón Querejeta; Begoña López; Arantxa González; Mariano Larman; José L Martínez Ubago
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

Review 5.  Recent Advances in Imaging of Hypertensive Heart Disease.

Authors:  Christopher L Schumann; Nicholas R Jaeger; Christopher M Kramer
Journal:  Curr Hypertens Rep       Date:  2019-01-14       Impact factor: 5.369

6.  Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure.

Authors:  Chandan K Nagaraju; Emma L Robinson; Mouna Abdesselem; Sander Trenson; Eef Dries; Guillaume Gilbert; Stefan Janssens; Johan Van Cleemput; Filip Rega; Bart Meyns; H Llewelyn Roderick; Ronald B Driesen; Karin R Sipido
Journal:  J Am Coll Cardiol       Date:  2019-05-14       Impact factor: 24.094

7.  Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone.

Authors:  Sujith Kuruvilla; Rajesh Janardhanan; Patrick Antkowiak; Ellen C Keeley; Nebiyu Adenaw; Jeremy Brooks; Frederick H Epstein; Christopher M Kramer; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2015-01-07

8.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Authors:  Elsayed Z Soliman; Walter T Ambrosius; William C Cushman; Zhu-Ming Zhang; Jeffrey T Bates; Javier A Neyra; Thaddeus Y Carson; Leonardo Tamariz; Lama Ghazi; Monique E Cho; Brian P Shapiro; Jiang He; Lawrence J Fine; Cora E Lewis
Journal:  Circulation       Date:  2017-05-16       Impact factor: 29.690

9.  Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors.

Authors:  I W Franz; U Tönnesmann; J F Müller
Journal:  Am J Hypertens       Date:  1998-06       Impact factor: 2.689

10.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.